Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices ...

[Image courtesy of Dexcom] After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set for more milestones in 2025 ... really big and we continued our U.S. growth and ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. DexCom develops continuous glucose monitoring (CGM) devices that help ...

Dexcom will release its annual earnings report on February 13. DXCM was up by 5.47 percent at $82.01 in the pre-market trade on the Nasdaq. DexCom NewsMORE Related Stocks Indices Commodities ...

DexCom (NASDAQ:DXCM) shares popped 6% premarket on Monday after the company set its financial forecast for 2025, projecting adjusted gross profit margin of around 64% – 65% on revenue of $4.60B ...

DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2024. In response, the company’s stock jumped 2.7% on Jan. 13. The company is scheduled to release its ...

For 2025, Dexcom expects revenue of $4.6 billion. MedTech Dive caught up with Sayer for more details on Dexcom’s strategy for over-the-counter sensors and other plans for this year, including a study ...